High Activity of Fosfomycin and Rifampin against Methicillin-Resistant Staphylococcus aureus Biofilm In Vitro and in an Experimental Foreign-Body Infection Model

Activities of Fosfomycin, Tigecycline, Colistin, and Gentamicin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Foreign-Body Infection Model

(2013) Stéphane Corvec et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activities of Fosfomycin and Rifampin on Planktonic and Adherent Enterococcus faecalis Strains in an Experimental Foreign-Body Infection Model

(2013) Alessandra Oliva et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Daptomycin and Tigecycline Have Broader Effective Dose Ranges than Vancomycin as Prophylaxis against a Staphylococcus aureus Surgical Implant Infection in Mice

(2012) Jared A. Niska et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High-Dose Daptomycin plus Fosfomycin Is Safe and Effective in Treating Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Endocarditis

(2012) José M. Miró et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fosfomycin-Daptomycin and Other Fosfomycin Combinations as Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus

(2012) C. Garrigós et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of Rifampin against Propionibacterium acnes BiofilmIn Vitroand in an Experimental Foreign-Body Infection Model

(2012) Ulrika Furustrand Tafin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Gentamicin Improves the Activities of Daptomycin and Vancomycin against Enterococcus faecalis In Vitro and in an Experimental Foreign-Body Infection Model

(2011) Ulrika Furustrand Tafin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Daptomycin, Fosfomycin, or Both for Treatment of Methicillin-Resistant Staphylococcus aureus Osteomyelitis in an Experimental Rat Model

(2011) W. Poeppl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibacterial agents: back to the future? Can we live with only colistin, co-trimoxazole and fosfomycin?

(2011) J. Carlet et al.   CLINICAL MICROBIOLOGY AND INFECTION

Fosfomycin: an old—new antibiotic

(2011) R. Raz   CLINICAL MICROBIOLOGY AND INFECTION

Efficacy of Fosfomycin in Experimental Osteomyelitis Due to Methicillin-ResistantStaphylococcus aureus

(2010) W. Poeppl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characteristics and outcome of 27 elbow periprosthetic joint infections: results from a 14-year cohort study of 358 elbow prostheses

(2010) Y. Achermann et al.   CLINICAL MICROBIOLOGY AND INFECTION

Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention

(2010) O. C. Helou et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin

(2010) M. E. Pachón-Ibáñez et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria

(2010) Antonia C. Kastoris et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacodynamic assessment of vancomycin-rifampicin combination against methicillin resistantStaphylococcus aureusbiofilm: a parametric response surface analysis

(2010) Ahmed H. Salem et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Activities of Daptomycin and Vancomycin Alone and in Combination with Rifampin and Gentamicin against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Isolates in an Experimental Model of Endocarditis

(2009) K. L. LaPlante et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of Daptomycin in Implant-Associated Infection Due to Methicillin-Resistant Staphylococcus aureus: Importance of Combination with Rifampin

(2009) A.-K. John et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isothermal micro calorimetry – a new method for MIC determinations: results for 12 antibiotics and reference strains of E. coli and S. aureus

(2009) Ueli von Ah et al.   BMC MICROBIOLOGY

Fosfomycin: an old, new friend?

(2009) M. Popovic et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model

(2009) Y. Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection

(2009) M. V. Schintler et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Linezolid Alone or Combined with Rifampin against Methicillin-Resistant Staphylococcus aureus in Experimental Foreign-Body Infection

(2008) D. Baldoni et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment of Joint Prosthesis Infection in Accordance with Current Recommendations Improves Outcome

(2008) Belinda Y. Betsch et al.   CLINICAL INFECTIOUS DISEASES